Abstract:Background: The extensive community of gut microbiota significantly influences various biological functions throughout the body, making its characterization a focal point in biomedicine research. Over the past few decades, studies have revealed a potential link between specific gut bacteria, their associated metabolic pathways, and influenza. Bacterial metabolites can communicate directly or indirectly with organs beyond the gut via the intestinal barrier, thereby impacting the physiological functions of the host. As the microbiota increasingly emerges as a 'gut signature' in influenza, gaining a deeper understanding of its role may offer new insights into its pathophysiological relevance and open avenues for novel therapeutic targets. In this Review, we explore the differences in gut microbiota between healthy individuals and those with influenza, the relationship between gut microbiota metabolites and influenza, and potential strategies for preventing and treating influenza through the regulation of gut microbiota and its metabolites, including fecal microbiota transplantation and microecological preparations. Methods: We utilized PubMed and Web of Science as our search databases, employing keywords such as "influenza," "gut microbiota," "traditional Chinese medicine," "metabolites," "prebiotics," "probiotics," and "machine learning" to retrieve studies examining the potential therapeutic connections between the modulation of gut microbiota and its metabolites in the treatment of influenza. The search encompassed literature from the inception of the databases up to December 2023. Results: Fecal microbiota transplantation (FMT), microbial preparations (probiotics and prebiotics), and traditional Chinese medicine have unique advantages in regulating intestinal microbiota and its metabolites to improve influenza outcomes. The primary mechanism involves increasing beneficial intestinal bacteria such as Bacteroidetes and Bifidobacterium while reducing harmful bacteria such as Proteobacteria. These interventions act directly or indirectly on metabolites such as short-chain fatty acids (SCFAs), amino acids (AAs), bile acids, and monoamines to alleviate lung inflammation, reduce viral load, and exert anti-influenza virus effects. Conclusion: The gut microbiota and its metabolites have direct or indirect therapeutic effects on influenza, presenting broad research potential for providing new directions in influenza research and offering references for clinical prevention and treatment. Future research should focus on identifying key strains, specific metabolites, and immune regulation mechanisms within the gut microbiota to accurately target microbiota interventions and prevent respiratory viral infections such as influenza.

The gut-lung axis in influenza A: the role of gut microbiota in immune balance

Research progress on the mechanism of traditional Chinese medicine regulating intestinal microbiota to combat influenza a virus infection

Influenza and the gut microbiota: A hidden therapeutic link

Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations

Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions

Signals from intestinal microbiota mediate the crosstalk between the lung-gut axis in an influenza infection mouse model

An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection

Genetically Predicted Peripheral Immune Cells Mediate the Effect of Gut Microbiota on Influenza Susceptibility

Dynamic Changes in the Microbiome and Mucosal Immune Microenvironment of the Lower Respiratory Tract by Influenza Virus Infection

Identification of Causal Relationships between Gut Microbiota and Influenza a Virus Infection in Chinese by Mendelian Randomization

Respiratory Antiviral Immunity and Immunobiotics: Beneficial Effects on Inflammation-Coagulation Interaction during Influenza Virus Infection

Effects of Intestinal Microorganisms on Influenza-Infected Mice with Antibiotic-Induced Intestinal Dysbiosis, through the TLR7 Signaling Pathway

Intestinal Microbiota Metabolizing Houttuynia Cordata Polysaccharides in H1N1 Induced Pneumonia Mice Contributed to Th17/Treg Rebalance in Gut-Lung Axis.

Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection

The Potential Role of Probiotics in Protection against Influenza a Virus Infection in Mice

Akkermansia muciniphila Improves Host Defense Against Influenza Virus Infection

The metabolic role of gut dysbiosis in altered T cell responses to influenza virus infection

Avian influenza and gut microbiome in poultry and humans: A "One Health" perspective

Role of the intestinal microbiota in host defense against respiratory viral infections

Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice.

Intestinal Microbiota—A Promising Target for Antiviral Therapy?